Subtopic Deep Dive
Podoplanin expression in lymphatic endothelium
Research Guide
What is Podoplanin expression in lymphatic endothelium?
Podoplanin expression in lymphatic endothelium refers to the specific upregulation and functional role of podoplanin, a mucin-type transmembrane glycoprotein, as a marker in lymphatic endothelial cells during inflammation, tumor progression, and lymphangiogenesis.
Podoplanin serves as a key lymphatic marker expressed in endothelial cells, distinguishing them from vascular endothelium. Research shows its upregulation in human squamous cell carcinomas and germ cell tumors (Schacht et al., 2005, 595 citations). Studies link it to lymphatic vessel hyperplasia in chronic inflammation (Bałuk et al., 2005, 543 citations). Over 10 high-citation papers from 2001-2014 explore its role in metastasis and macrophage-driven lymphangiogenesis.
Why It Matters
Podoplanin expression enables identification of lymphatic vessels in tumors, aiding diagnosis of metastasis risk via peritumoral lymphangiogenesis (Schoppmann et al., 2002, 777 citations). It supports development of imaging techniques and therapeutic antibodies targeting platelet interactions for anti-metastatic interventions (Karaman and Detmar, 2014, 598 citations). In inflammatory diseases like asthma, podoplanin marks persistent lymphatic hyperplasia, informing edema treatments (Bałuk et al., 2005). Schacht et al. (2005) demonstrated its diagnostic utility in carcinomas, impacting oncology pathology.
Key Research Challenges
Specificity of podoplanin marking
Podoplanin marks lymphatic endothelium but shows inconsistent expression in tumors versus normal tissues (Schacht et al., 2005). Distinguishing pathological upregulation from baseline requires better co-markers like Prox1 (Wigle, 2002). Validation across disease models remains limited.
Mechanisms of platelet interactions
Podoplanin mediates endothelial migration and platelet aggregation in lymphangiogenesis, but exact pathways in metastasis are unclear (Karaman and Detmar, 2014). Inflammation-induced expression involves macrophages, complicating isolation (Maruyama et al., 2005). Therapeutic targeting risks bleeding complications.
Quantifying expression in vivo
Imaging podoplanin in dynamic lymphatic hyperplasia during airway inflammation poses technical hurdles (Bałuk et al., 2005). VEGF-A driven recruitment lacks podoplanin-specific metrics (Cursiefen et al., 2004). High-resolution models for real-time tracking are needed.
Essential Papers
VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment
Claus Cursiefen, Lu Chen, Leonardo P. Borges et al. · 2004 · Journal of Clinical Investigation · 1.0K citations
Lymphangiogenesis, an important initial step in tumor metastasis and transplant sensitization, is mediated by the action of VEGF-C and -D on VEGFR3. In contrast, VEGF-A binds VEGFR1 and VEGFR2 and ...
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
Stefano J. Mandriota · 2001 · The EMBO Journal · 971 citations
An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype
Jeffrey T. Wigle · 2002 · The EMBO Journal · 932 citations
Tumor-Associated Macrophages Express Lymphatic Endothelial Growth Factors and Are Related to Peritumoral Lymphangiogenesis
Sebastian F. Schoppmann, Peter Birner, Johannes Stöckl et al. · 2002 · American Journal Of Pathology · 777 citations
Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages
Kazuichi Maruyama, Masaaki Ii, Claus Cursiefen et al. · 2005 · Journal of Clinical Investigation · 713 citations
In the inflamed cornea, there is a parallel outgrowth of blood and lymphatic vessels into the normally avascular cornea. We tested whether adaptive and/or innate immune cells were actively involved...
Mechanisms of lymphatic metastasis
Sinem Karaman, Michael Detmar · 2014 · Journal of Clinical Investigation · 598 citations
Malignant tumors release growth factors such as VEGF-C to induce lymphatic vessel expansion (lymphangiogenesis) in primary tumors and in draining sentinel LNs, thereby promoting LN metastasis. Surp...
Up-Regulation of the Lymphatic Marker Podoplanin, a Mucin-Type Transmembrane Glycoprotein, in Human Squamous Cell Carcinomas and Germ Cell Tumors
Vivien Schacht, Soheil S. Dadras, Louise A. Johnson et al. · 2005 · American Journal Of Pathology · 595 citations
Reading Guide
Foundational Papers
Start with Wigle (2002, 932 citations) for Prox1-podoplanin endothelial phenotype induction, then Schacht et al. (2005, 595 citations) for tumor expression, and Cursiefen et al. (2004, 1000 citations) for VEGF-A context.
Recent Advances
Prioritize Karaman and Detmar (2014, 598 citations) on metastasis mechanisms and Schaaf et al. (2018, 585 citations) on tumor vasculature immunity links to podoplanin.
Core Methods
Core techniques: immunohistochemistry for podoplanin detection (Schacht et al., 2005), macrophage depletion models (Maruyama et al., 2005), and VEGF blockade in lymphangiogenesis assays (Cursiefen et al., 2004).
How PapersFlow Helps You Research Podoplanin expression in lymphatic endothelium
Discover & Search
Research Agent uses searchPapers and exaSearch to find podoplanin-focused papers like 'Up-Regulation of the Lymphatic Marker Podoplanin' (Schacht et al., 2005), then citationGraph reveals connections to macrophage lymphangiogenesis (Schoppmann et al., 2002) and findSimilarPapers expands to Prox1 induction (Wigle, 2002).
Analyze & Verify
Analysis Agent applies readPaperContent to extract podoplanin expression data from Schacht et al. (2005), verifies claims with CoVe against Cursiefen et al. (2004), and uses runPythonAnalysis for statistical comparison of citation-normalized expression levels across 10 papers with GRADE scoring for evidence strength in metastasis models.
Synthesize & Write
Synthesis Agent detects gaps in podoplanin-platelet interaction studies post-2014, flags contradictions between tumor (Schacht et al., 2005) and inflammation models (Bałuk et al., 2005); Writing Agent employs latexEditText, latexSyncCitations for 20-paper review, and latexCompile to generate publication-ready manuscripts with exportMermaid diagrams of lymphangiogenesis pathways.
Use Cases
"Extract and plot podoplanin expression levels from tumor lymphangiogenesis papers"
Research Agent → searchPapers('podoplanin lymphatic endothelium tumors') → Analysis Agent → readPaperContent(Schacht 2005) + runPythonAnalysis(pandas plot of expression data across 5 papers) → matplotlib figure of upregulation trends.
"Write LaTeX review on podoplanin in lymphatic metastasis with citations"
Research Agent → citationGraph(Karaman 2014) → Synthesis Agent → gap detection → Writing Agent → latexEditText(draft sections) → latexSyncCitations(15 papers) → latexCompile(PDF review with podoplanin pathway figure).
"Find code for podoplanin imaging analysis in lymphatic papers"
Research Agent → searchPapers('podoplanin lymphatic imaging code') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect (quantification scripts) → runPythonAnalysis (test on Bałuk 2005 vessel density data).
Automated Workflows
Deep Research workflow systematically reviews 50+ podoplanin papers: searchPapers → citationGraph → DeepScan (7-step verification with CoVe on Schacht/Schoppmann claims). Theorizer generates hypotheses on podoplanin-VEGF-A interactions from Cursiefen (2004) and Wigle (2002), outputting mermaid diagrams. DeepScan analyzes macrophage-podoplanin links with GRADE checkpoints.
Frequently Asked Questions
What defines podoplanin expression in lymphatic endothelium?
Podoplanin is a mucin-type glycoprotein upregulated as a marker in lymphatic endothelial cells, distinguishing them in tumors and inflammation (Schacht et al., 2005).
What are key methods for studying podoplanin expression?
Immunohistochemistry detects podoplanin in peritumoral lymphatics (Schoppmann et al., 2002); mouse models track VEGF-driven upregulation (Cursiefen et al., 2004).
What are the highest-cited papers?
Top papers include Cursiefen et al. (2004, 1000 citations) on VEGF-A lymphangiogenesis and Schacht et al. (2005, 595 citations) on tumor podoplanin.
What open problems exist?
Challenges include podoplanin specificity in mixed vascular beds and therapeutic targeting without hemostasis disruption (Karaman and Detmar, 2014).
Research Lymphatic System and Diseases with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Podoplanin expression in lymphatic endothelium with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Lymphatic System and Diseases Research Guide